Search

ChatPaper

AI Writing

Analysis

Open Data

More

Journal&Conference

Master Reading Tree

Xiaomai's Star Talents

AI sign Language

Log in

Academic Profile User Profile

My Following Paper Collections Browse History

POSTER: MM-360 Mezigdomide (MEZI) Plus Dexamethasone (DEX) in Relapsed/Refractory Multiple Myeloma (RRMM): Results From the Dose-Expansion Phase of the CC-92480-MM-001 Trial

Robert Z. Orlowski,Nizar J. Bahlis,Hang Quach,Rakesh Popat,Sagar Lonial,Kihyun Kim,María-Victoria Mateos,Charlotte Pawlyn, Karthik Ramasamy, Joaquín Martínez-Lopez,Ignacio Casas-Avilés,Alessia Spirlì,Jing Gong, Michael Amatangelo,Jessica Katz,Paulo Maciag,Teresa Peluso,Paul G. Richardson,Suzanne Trudel

Clinical Lymphoma, Myeloma & Leukemia（2023）

Cited 0|Views4

No score

Key words

RRMM,clinical trial,phase 1/2,immunomodulation,CELMoDs

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined